PTC Therapeutics, Inc. Letters of Credit Outstanding, Amount
PTC Therapeutics, Inc. (PTCT) had Letters of Credit Outstanding, Amount of $7.50 million as of 2022-03-31, per its 10-Q filed 2022-05-03.
Discontinued › Notes
us-gaap:LettersOfCreditOutstandingAmount · last filed 2023-02-21
- 2022-03-31: Letters of Credit Outstanding, Amount $7.50M.
- 2021-09-30: Letters of Credit Outstanding, Amount $7.50M.
- 2021-06-30: Letters of Credit Outstanding, Amount $7.50M.
- 2021-03-31: Letters of Credit Outstanding, Amount $7.50M.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2022-03-31 | $7.50M 10-Q · filed 2022-05-03 |
| 2021-09-30 | $7.50M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $7.50M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $7.50M 10-Q · filed 2021-05-04 |
| 2020-09-30 | $7.50M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $7.50M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $7.50M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $7.50M 10-K · filed 2023-02-21 |
| 2019-09-30 | $7.50M 10-Q · filed 2019-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |